You are not using a standards compliant browser. Because of this you may notice minor glitches in the rendering of this page. Please upgrade to a compliant browser for optimal viewing:
Internet Explorer 7
Safari (Mac and PC)
Antibody De Novo Sequencing
The amino acid sequence of therapeutic antibody plays a critical role in the rising biopharmaceutical industry for antibody drug discovery and development, regulatory filing and intellectual property protection.

De Novo sequencing of therapeutic antibodies and other proteins is a technology to sequence the proteins without the database searching, and get the sequence by LC-MS/MS, software processing, and bioinformatics.
Group Members (1): See all
Group Discussion Forum
There are no threads in this group, Start one!